Gilead Sciences

Principal Medical Key Account Lead- Pacific Northwest

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Principal Medical Key Account Lead, US Medical Affairs Patient Access, and Quality of Care (PAQ)

Employment Type: Full time Location: Northern CA, WA, and OR

Position Overview

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfill their aspirations. Join Gilead and help create possible, together.

Key Responsibilities

The Medical Key Account Lead (MKAL) will be responsible for leading the medical interface among key HIV and oncology health systems, academic medical centers, GPOs, and Pathway accounts. This interface involves developing sustainable enterprise customer relationships and communicating comprehensive clinical, scientific, health economic and outcomes research (HEOR), including real world evidence and patient reported outcomes.

  • This position will be responsible for developing and maintaining access to the key account stakeholders to facilitate the appropriate scientific interchange for all Gilead HIV and oncology innovations, including Gilead’s pipeline assets with priority placed upon launch products.
  • Will be responsible for the development of strategic medical plans and tactics for their accounts, and implementation of customer-specific Real-World Evidence (RWE) data generation and will work closely with the PAQ strategy teams to interpret and disseminate data and information assessing and communicating the medical value of Gilead’s portfolio.
  • Assigned to approximately 10-15 critical key accounts. These customers are primarily the largest US academic health and key health systems.
  • The MKAL will work closely with the Commercial Oncology Key Account Directors and HIV Institutional Account Directors as it relates to external stakeholder needs and engagements.
  • Will also work closely with Therapeutic Area Medical Science Liaisons, Clinical Development, Clinic Operations, and home office medical matrix teams to facilitate deep scientific product exchange.
  • The Medical Key Account Lead will provide strong leadership in developing the medical strategy for their accounts as it relates to patient access, the evolving healthcare environment, and their customers.

Additional Responsibilities

  • Effectively communicate approved clinical, scientific, and outcomes data, and accurately respond to customer questions during a scientific exchange. They must be knowledgeable about the full data/information available.
  • The audience for these interactions at the assigned key accounts are usually access and policy decision-makers, department heads and chairs, executive medical and institutional stakeholders, scientific advisors, healthcare policymakers, nationally recognized health economists, and population health experts.
  • Interactions with these stakeholders will take place in accordance with Company Policies, applicable laws, regulations, and ethical standards.
  • Gain insights into (1) formulary, policy, and reimbursement strategies (2) outcomes and real-world evidence

Company Information

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Skills

HIV
Oncology
Health Systems
Academic Medical Centers
GPOs
Pathway Accounts
Clinical
Scientific Interchange
Health Economics
Outcomes Research (HEOR)
Real World Evidence
Patient Reported Outcomes

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI